
Source: iQoncept / Shutterstock
Lantern Pharma (NASDAQ:LTRN) has released its financial performance for the fourth quarter of 2023.
- Exceeding expectations, Lantern Pharma posted earnings per share of -39 cents, surpassing the anticipated -40 cents.
- The quarter, however, did not witness any revenue generation by the company.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/ltrn-stock-earnings-lantern-pharma-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC